PANACEA BIOTEC
Back to Income Statement
|
PANACEA BIOTEC Last 5 Year Revenue History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Sales | ₹559 Cr | ₹559 Cr | ₹460 Cr | ₹661 Cr | ₹625 Cr |
What is the latest Revenue of PANACEA BIOTEC ?
| Year | Revenue |
|---|---|
| Mar2025 | ₹559 Cr |
| Mar2024 | ₹559 Cr |
| Mar2023 | ₹460 Cr |
| Mar2022 | ₹661 Cr |
| Mar2021 | ₹625 Cr |
How is Revenue of PANACEA BIOTEC Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2025 | ₹559 Cr | -0.01 | |
| Mar2024 | ₹559 Cr | 21.57 | |
| Mar2023 | ₹460 Cr | -30.44 | |
| Mar2022 | ₹661 Cr | 5.83 | |
| Mar2021 | ₹625 Cr | - | |
Compare Revenue of peers of PANACEA BIOTEC
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| PANACEA BIOTEC | ₹2,051.4 Cr | -5.2% | -3.6% | 6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹415,217.0 Cr | 0.4% | 5.6% | 1.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹166,047.0 Cr | -0.5% | 3.3% | 7.9% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹148,872.0 Cr | 4.5% | 10% | 41.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹108,454.0 Cr | 1.5% | 4.8% | 9.1% | Stock Analytics | |
| CIPLA | ₹107,136.0 Cr | -1.7% | 1% | -10.5% | Stock Analytics | |
PANACEA BIOTEC Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| PANACEA BIOTEC | -5.2% |
-3.6% |
6% |
| SENSEX | -1.5% |
0.8% |
8.2% |
You may also like the below Video Courses